ALNY

Alnylam Pharmaceuticals News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Alnylam Pharmaceuticals Inc ALNY NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.27 -0.15% 181.83 20:00:00
Open Price Low Price High Price Close Price Prev Close
183.43 180.50 184.45 181.83 182.10
more quote information »

Recent News

Date Time Source Heading
7/29/20216:00IHNWFeaturedElectromedical Technologies and Nazarbayev University to Commence Landmark Alzheimer's Disease Research Program
7/29/202111:00IHNWFeaturedEmerging Markets Report: Catching Up with Liberty Defense
7/29/202117:00BWAlnylam and PeptiDream Enter into Collaboration Agreement to..
7/29/202108:16SEEKAlnylam is lower after releasing topline data for lumasiran..
7/29/202107:00BWAlnylam Reports Positive Topline Results from ILLUMINATE-C..
7/21/202108:00BWAlnylam to Webcast Conference Call Discussing Second Quarter..
7/19/202116:24EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:23EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202116:20EDGARStatement of Changes in Beneficial Ownership (4)
7/14/202116:59EDGARStatement of Changes in Beneficial Ownership (4)
6/30/202107:24SEEKAlnylam launches mid-stage zilebesiran study in hypertension
6/30/202107:00BWAlnylam Initiates KARDIA-1 Phase 2 Study of Zilebesiran..
6/24/202107:00BWAlnylam Announces U.S. Food & Drug Administration Acceptance..
6/23/202107:00BWAlnylam to Host Eighth Annual “RNAi Roundtable” Webcast..
6/22/202116:08EDGARStatement of Changes in Beneficial Ownership (4)
6/11/202116:14EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202107:30BWAlnylam Announces New Data from ATTR Amyloidosis Programs at..
6/01/202107:00BWAlnylam Completes Enrollment in APOLLO-B Phase 3 Study of..
5/26/202116:00BWAlnylam to Webcast Presentations at Upcoming June Investor..
5/21/202116:31EDGARCurrent Report Filing (8-k)
5/17/202119:26EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202107:00BWAlnylam Announces New Advances in ATTR Amyloidosis Program
5/04/202108:00BWAlnylam to Webcast Presentations at Upcoming May Investor..
5/03/202107:41SEEKAlnylam reports positive early Oxlumo data in rare kidney..
5/03/202107:00BWAlnylam Announces Positive Early Results on Clinical Outcome..
4/29/202116:14EDGARQuarterly Report (10-q)
4/29/202108:34SEEKAlnylam posts Q1 results, reiterates financial forecast
4/29/202108:12EDGARCurrent Report Filing (8-k)
4/29/202108:06SEEKAlnylam Pharmaceuticals EPS misses by $0.24, beats on..
4/29/202108:00BWAlnylam Pharmaceuticals Reports First Quarter 2021 Financial..
4/28/202112:49SEEKAlnylam Pharmaceuticals Q1 2021 Earnings Preview
4/21/202118:23EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202118:23EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202118:22EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202118:21EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202118:21EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202115:19SEEKAlnylam submits NDA for RNAi drug vutrisiran to FDA
4/19/202114:00BWAlnylam Presents Positive Results from HELIOS-A Phase 3..
4/15/202108:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
4/12/202117:01EDGARCurrent Report Filing (8-k)
4/12/202102:52TRMNAlnylam Reports Positive Interim Results From Phase 1 Study..
4/11/202112:09SEEKAlnylam RNAi candidate ALN-AGT lowers blood pressure in..
4/11/202110:28BWAlnylam Presents Positive Late-Breaking Data from Ongoing..
4/08/202107:58SEEKRoyalty Pharma acquires Oxlumo royalty interest from Dicerna
4/06/202108:00BWAlnylam to Webcast Presentation at 20th Annual Needham..
4/02/202116:48EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/02/202116:47EDGARProxy Statement (definitive) (def 14a)
3/31/202117:00BWAlnylam Announces Publication of ILLUMINATE-A Phase 3 Study..
See more news about this stock »


Your Recent History
NASDAQ
ALNY
Alnylam Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.